Methadone maintenance therapy outcomes in Iran

Substance Use and Misuse

Volumn 47, Issue 7, 2012, Pages 767-773

  Noori, Roya ^a   Narenjiha, Homan ^a   Aghabakhshi, Habibollah ^a   Habibi, Gholamreza ^b   Khoshkrood Mansoori, Babak ^b  

^a Research Center of Substance Abuse and Dependency   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Harm reduction; Injecting drug users; Methadone maintenance therapy

Indexed keywords

METHADONE;

ADAPTIVE BEHAVIOR; ADDICTION; ADULT; ARTICLE; CASE CONTROL STUDY; CRIME; DRUG ABUSE; DRUG EFFECT; HARM REDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAN; MALE; METHODOLOGY; MIDDLE AGED; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; PSYCHOLOGICAL ASPECT; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; STATISTICS; SUBSTANCE ABUSE; UNSAFE SEX;

ADAPTATION, PSYCHOLOGICAL; ADULT; CASE-CONTROL STUDIES; CRIME; HARM REDUCTION; HIV INFECTIONS; HUMANS; IRAN; MALE; METHADONE; MIDDLE AGED; NEEDLE SHARING; OPIATE SUBSTITUTION TREATMENT; PREVALENCE; SEXUAL BEHAVIOR; SOCIAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; SUBSTANCE-RELATED DISORDERS; UNSAFE SEX;

EID: 84860474592     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.3109/10826084.2010.517726     Document Type: Article

References (34)

1. AIDS Epidemic Update. (2006). Middle East and North Africa. Geneva: UNAIDS. Retrieved from www.unaids. org/en/HIV data/epi2006
2. Ball, J. C., & Ross, A. (1991). The effectiveness of methadone maintenance treatment. American Journal of Public Health, 81, 1185-1200.
3. Des Jarlais, D. C. (1996). HIV incidence among injecting drug users inNewYork City syringe exchange programs. Lancet, 348, 1797-1800.
4. Drucker, E. (1995). Harm reduction: A public health strategy. Current Issues in Public Health, 1, 64-70.
5. Emmanuelli, J., & Desenclos, J. C. (2005). Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003. Addiction, 100, 1690-1700. (Pubitemid 41626829)
6. Farrell, M., Ward, J., Mattick, R., Hall, W., Stimson, G. V., des Jarlais, D., et al. (1996). Methadone maintenance treatment for opiate dependence: A review. British Medical Journal, 313, 270-272.
7. Food and Drug Administration. (2006). FDA warning issued. Retrieved from http://www.fda.gov/medwatch/safety/2006/safety06.htm#Methadone
8. Gheiratmand, R., Navipour, R., Mohebbi, M. R., & Mallik, A. K. (2005). Uncertainty on the number of HIV/AIDS patients: Our experience in Iran. Sex Transmitted Infections, 81, 279-280. (Pubitemid 40835062)
9. Harwood, H., Hubbard, R., Collins, J., & Rachal, J. V. (1988). The costs of crime and the benefits of drug abuse treatment: A cost-benefit analysis using TOPS data. In C. G. Leukefeld & F. M. Time (Eds.), Compulsory treatment of drug abuse: Research and clinical practice, NIDA Research Monograph Series 86. Rockville, MD: National Institute on Drug Abuse.
10. Hawks, D., & Lenton, S. (1995). Harm reduction in Australia: Has it worked? A review. Drug Alcohol Review, 14, 291-304.
11. Hurley, S. F., Jolly, D. J., & Kaldor, J. M. (1997). Effectiveness of needle-exchange programs for prevention of HIV infection. Lancet, 349, 1797-1800. (Pubitemid 27257556)
12. Index Mundi. (2007). Iran unemployment rate. Retrieved November 7, 2007, from http://www.indexmundi.com/iran/unemployment rate.html
13. Iranian Ministry of Health andMedical Education. (2003). Statistics on HIV/AIDS in Iran [in Persian]. Tehran: Author.
14. Iverson, G. (1991). Contextual analysis. Newbury Park, CA: Sage.
15. Laxminarayan, R., Milles, A., Breman, J. G., Measham, A. R., Alleyne, G., Claeson, M., et al. (2006). Advancement of global health: Key messages from the Disease Control Priorities Project. Lancet, 367, 1193-1208.
16. LeCompte, M. D., & Schensul, J. J. (1999). Analyzing and interpreting ethnographic data from the Ethnographer's Toolkit (vol. 5). Walnut Creek, CA: AltaMira.
17. Marsch, L. (1998). The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: A meta-analysis. Addiction, 93, 515-532. (Pubitemid 28188071)
18. Martell, B. A., Arnsten, J. H., Ray, B., & Gourevitch, M. N. (2003). The impact of methadone induction on cardiac conduction in opiate users. Annals of Internal Medicine, 139, 154-155. (Pubitemid 38129111)
19. Mokri, A. (2002). Brief overview of the status of drug abuse in Iran. Retrieved from http://www.ams.ac.ir/AIM/0253/0253184.htm
20. Monitoring the AIDS Pandemic. (2001). The status and trends of HIV/AIDS/STI epidemics in Asia and the Pacific (MAP Provisional Report). Washington, DC: Author.
21. Monitoring the AIDS Pandemic. (2004). AIDS in Asia: Face the facts-A comprehensive analysis of the AIDS epidemic in Asia. Washington, DC: Author.
22. Nissaramanesh, B., Trace, M., & Roberts, M. (2005). The rise of harm reduction in the Islamic Republic of Iran: The Beckley Foundation drug policy program. Retrieved July 8, 2007, from http://www.internationaldrugpolicy.net/ reports/BeckleyFoundation Briefi ngPaper 08.pdf
23. Ohiri, K., Claeson, M., Razzaghi, E., Nassirimanesh, B., Afshar, P., &Power, R. (2006). HIV/AIDS prevention among injecting drug users: Learning from harm reduction in Iran. Retrieved from http://siteresources.worldbank.org/ INTSAREGTOPHIVAIDS/Resources/LancetHarmReductionIran.pdf
24. Ramezani, A., Mohraz, M., & Gachkar, L. (2006). Epidemiologic situation of human immunodeficiency virus (HIV/AIDS patients) in a private clinic in Tehran, Iran. Archives of Iranian Medicine, 9, 315-318. (Pubitemid 44803570)
25. Razzaghi, E., Nassirimanesh, B., Afshar, P., Ohiri, K., Claeson. M., & Power, R. (2006). HIV/AIDS harm reduction in Iran. Lancet, 368, 434-435. (Pubitemid 44142754)
26. Razzaghi, E. M., Mokri, A., & Vazirian, M. (2005). Effectiveness of methadone maintenance program in reducing illicit drug use and HIV related high-risk behavior: A multicenter study. Retrieved from http://www.unodc.org/ pdf/iran/publications/ MMT%20Pilot%20report%20for%20UNODC%20final%20(March%202005).pdf
27. Razzaghi, E. M., Movaghar, A. R., Green, T. C., & Khoshnood, K. (2006). Profiles of risk: A qualitative study of injecting drug users in Tehran, Iran. Harm Reduction Journal, 3, 12.
28. Sheerin, I., Green, T., Sellman, D., Adamson, S., & Deering, D. (2004). Reduction in crime by drug users on a methadone maintenance therapy program in New Zealand. New Zealand Medical Journal, 117, 1190.
29. Stimson, G. V., Fitch, C., & Rhodes, T. (Eds.). (1998). The rapid assessment and response guide for injecting drug use. Geneva: World Health Organization.
30. United Nations Office on Drugs and Crime. (2004). World Drug Report 2004. Vienna: Author. Retrieved from http://www.unodc.org/unodc/en/world drug report 2004.html
31. United Nations Office on Drugs and Crime. (2005). World Drug Report 2005. Vienna: Author. Retrieved from http://www.unodc.org/unodc/es/world drug report 2005.html
32. The World Bank. (2006). Preventing HIV/AIDS in the Middle East and North Africa: A window of opportunity to act. Retrieved from http://www.siteresources. worldbank.org/INTMENA/Resources/Preventing HIV Regional Strategy5.pdf
33. The World Bank Group Iran. (2007). Data profile of the Islamic Republic of Iran. Retrieved November 7, 2007, from http://devdata.worldbank.org/external/ CPProfile.asp?CCODE= IRN&PTYPE=CP
34. WHO/UNODC/UNAIDS. (2004). Position paper on Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention.